0001752026-26-000004.txt : 20260227 0001752026-26-000004.hdr.sgml : 20260227 20260227114013 ACCESSION NUMBER: 0001752026-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260227 DATE AS OF CHANGE: 20260227 EFFECTIVENESS DATE: 20260227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Linnaeus Therapeutics, Inc. CENTRAL INDEX KEY: 0001752026 ORGANIZATION NAME: EIN: 474846130 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-574940 FILM NUMBER: 26695069 BUSINESS ADDRESS: STREET 1: 30 WASHINGTON AVENUE, SUITE F CITY: HADDONFIELD STATE: NJ ZIP: 08033 BUSINESS PHONE: 856-433-1500 MAIL ADDRESS: STREET 1: 30 WASHINGTON AVENUE, SUITE F CITY: HADDONFIELD STATE: NJ ZIP: 08033 D 1 primary_doc.xml X0708 D LIVE 0001752026 Linnaeus Therapeutics, Inc. 30 WASHINGTON AVENUE, SUITE F HADDONFIELD NJ NEW JERSEY 08033 856-433-1500 DELAWARE None None Corporation true Patrick Mooney 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Executive Officer Director James Demetriades 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Director Michael Poisel 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Director Chris Arendt 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Director Todd Thomson 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Director John Lepping 30 Washington Avenue, Suite F Haddonfield NJ NEW JERSEY 08033 Director Biotechnology Decline to Disclose 06b false 2026-02-17 false true false 1 10000000 4475000 5525000 false 19 0 0 0 false Linnaeus Therapeutics, Inc. Anthony Gruzdis Anthony Gruzdis Attorney-in-fact 2026-02-27